Filing Details
- Accession Number:
- 0001415889-24-011664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-29 16:32:08
- Reporting Period:
- 2024-04-25
- Accepted Time:
- 2024-04-29 16:32:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626199 | Alpine Immune Sciences Inc. | ALPN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341382 | N James Topper | C/O Frazier Life Sciences 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-25 | 1,200,000 | $0.00 | 2,829,366 | No | 4 | X | Indirect | By: Frazier Life Sciences VIII, L.P. |
| Common Stock | Disposition | 2024-04-25 | 19 | $64.57 | 2,829,347 | No | 4 | S | Indirect | By: Frazier Life Sciences VIII, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Indirect | By: Frazier Life Sciences VIII, L.P. |
| No | 4 | S | Indirect | By: Frazier Life Sciences VIII, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (Right to Buy) | Disposition | 2024-04-25 | 1,200,000 | $0.00 | 1,200,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | X | Indirect |
Footnotes
- The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James N. Topper is one of two managing members of FHM LLC. Dr. Topper disclaims beneficial ownership of the securities held by FLS LP except for his pecuniary interest therein, if any.
- On April 25, 2024, Frazier Life Sciences VIII, L.P. exercised a warrant to purchase 1,200,000 shares of the Issuer's Common Stock at an exercise price of $0.001 per share. Frazier Life Sciences VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 19 shares of Common Stock to pay the exercise price and issuing Frazier Life Sciences VIII, L.P. the remaining 1,199,981 shares of Common Stock.
- The warrant had no expiration date and was exercisable immediately.
Billionaire Hedge Funds
